Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR6 | P50406 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 8/20 | 0.36 |
| ▸ | LMNA | P02545 | 7/20 | 0.36 |
| ▸ | MAPT | P10636 | 6/20 | 0.36 |
| ▸ | NPC1 | O15118 | 2/20 | 0.36 |
| ▸ | POLB | P06746 | 3/20 | 0.35 |
| ▸ | MMP2 | P08253 | 3/20 | 0.35 |
| ▸ | MMP9 | P14780 | 3/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 1/20 | 0.34 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6014544 | 0.81 | HTR6 (0.47) | HTR6TP53LMNAMAPTNPC1 | |
| SCHEMBL6014405 | 0.78 | HTR6 (0.48) | HTR6TP53LMNAMAPTNPC1 | |
| SCHEMBL6014471 | 0.77 | HTR6 (0.48) | HTR6POLBKMT2A | |
| SCHEMBL6014370 | 0.75 | HTR6 (0.50) | HTR6TP53LMNAMAPTKMT2A | |
| SCHEMBL6014472 | 0.74 | MMP2 (0.47) | HTR6TP53LMNAMAPTNPC1 | |
| SCHEMBL6014355 | 0.74 | MMP9 (0.48) | HTR6TP53LMNAMAPTNPC1 | |
| SCHEMBL6014512 | 0.73 | HTR6 (0.44) | HTR6TP53LMNAMAPTNPC1 | |
| SCHEMBL300386 | 0.73 | HTR6 (0.44) | HTR6TP53LMNAMAPTNPC1 | |
| SCHEMBL6014500 | 0.71 | MMP2 (0.43) | HTR6TP53LMNAMAPTNPC1 | |
| SCHEMBL6014557 | 0.71 | HTR6 (0.42) | HTR6TP53LMNAMAPTNPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100019169-A1 | REMOTE LASER INTERROGATION OF THREAT CLOUDS AND SURFACES | MICHIGAN MOLECULAR INSTITUTE (US) | 2010-01-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100019169-A1 | REMOTE LASER INTERROGATION OF THREAT CLOUDS AND SURFACES | SELL, LGALS2, LGALS4 | HTR6 3589/4885TP53 207/4885LMNA 133/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.